Lee IH, Lee SJ, Lee J, Jung JH, et al. Utility of (18)F-FDG PET/CT for predicting pathologic complete response in hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapy. BMC Cancer 2020;20:1106.
PMID: 33198673